Sumatriptan Suppliers & Bulk Manufacturers
Available Forms: Tablet / Nasal Spray / Injection
Available Strengths: 25 mg, 50 mg, 100 mg, 5 mg, 10 mg, 20 mg
Reference Brands: Imitrex (USA), Imigran (EU), Migraitan (EU)
Category:
Neurology
Sumatriptan is a serotonin (5-HT1) receptor agonist used to treat acute migraine attacks and cluster headaches. It works by narrowing the blood vessels around the brain and reducing inflammation, thereby alleviating headache symptoms.
Sumatriptan is available in Tablet / Nasal Spray / Injection
and strengths such as 25 mg, 50 mg, 100 mg, 5 mg, 10 mg, 20 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Sumatriptan is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Sumatriptan can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Sumatriptan, marketed under the brand name Imitrex and other regional brands, is a medication used for the acute treatment of migraine headaches and cluster headaches in adults. It is available in multiple dosage forms, including oral tablets, nasal spray, and subcutaneous administration, allowing flexible treatment based on patient needs and symptom severity. Sumatriptan belongs to the triptan class of drugs and acts as a selective serotonin (5-HT1B/1D) receptor agonist. By stimulating these receptors, it causes constriction of dilated cranial blood vessels and inhibits the release of inflammatory neuropeptides involved in headache pain.
Sumatriptan is indicated for the acute treatment of migraine with or without aura, as well as for cluster headaches. Therapeutic effects are typically observed within three hours of administration, with faster relief seen in non-oral formulations. Among the available options, the injected form is considered the most effective, particularly for severe or rapidly escalating attacks.
Sumatriptan is effective in terminating or significantly reducing the intensity of migraine and cluster headache episodes. When used appropriately under medical guidance, it provides rapid and reliable relief, helping patients regain normal function and improve quality of life during acute headache attacks.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing